Concepedia

Kanneganti Murthy

KM

Statistics

Publications

29

Citations

3.8K

H-Index

25

Active since

1991

Affiliations

Inotek Pharmaceuticals (United States)(Current)

Columbia University

Rutgers New Jersey Medical School

Rutgers, The State University of New Jersey

Semmelweis University

Kanneganti Murthy is an author at Inotek Pharmaceuticals (United States) specializing in life sciences, molecular biology, and inflammation.

Publications per year

1991–2010

29

Publications

29

Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation

Francisco García Soriano, László Virág, Prakash G. Jagtap et al. · Nature Medicine · 2001 · 603 citations · Full text

, , +14

Identification of redox/repair protein Ref-1 as a potent activator of p53.

L. Jayaraman, Kanneganti Murthy, Chunhong Zhu et al. · Genes & Development · 1997 · 478 citations · Full text

, , +8

High mobility group protein-1 (HMG-1) is a unique activator of p53

L. Jayaraman, Narayani Chandra Moorthy, Kanneganti Murthy et al. · Genes & Development · 1998 · 319 citations · Full text

, , +11

Transcription factor TFIID recruits factor CPSF for formation of 3′ end of mRNA

Jean-Christophe Dantonel, Kanneganti Murthy, James L. Manley et al. · Nature · 1997 · 308 citations

, , +13

Flagellin, a Novel Mediator of <i>Salmonella</i> -Induced Epithelial Activation and Systemic Inflammation: IκBα Degradation, Induction of Nitric Oxide Synthase, Induction of Proinflammatory Mediators, and Cardiovascular Dysfunction

Tonyia Eaves‐Pyles, Kanneganti Murthy, Lucas Liaudet et al. · The Journal of Immunology · 2001 · 269 citations · Full text

, , +16

1–5 of 29